Amgen, Oklahoma Health Care Authority and University of Oklahoma’s Pharmacy Management Consultants Partner to Improve Medicaid Outcomes
Amgen,
Amgen's
"I look forward to this collaboration providing valuable insights that will help improve patient outcomes and save money. It fully aligns with our goal to foster collaboration among public and private individuals and entities to build a responsive health care system for
The parties intend for initial research projects to use de-identified claims data to gain insights about medication adherence, missed diagnoses, heightened disease risk and other clinical indicators in
"This is an exciting collaboration for PMC because it closely fits with the data analysis we already undertake for OHCA on pharmaceutical utilization and outcomes," said
"Leveraging our collaborative research experience and population health unit, Amgen is excited to engage in our first partnership with a state Medicaid agency to evaluate and gain insights on Medicaid health plan data. Through this unique partnership, we look forward to working with OHCA and PMC to apply that information in identifying opportunities, including value-based programs, to improve costs, quality of care and the patient experience in
Globally, Amgen is engaged in over 75 distinct, value-based projects, spanning disease state collaborations, risk sharing, cost-cap programs, and outcomes-based agreements. The company has more than 25 ongoing partnerships in
About the
OHCA administers two health programs for the state. The first is SoonerCare,
About
About Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
The Michigan Republican Party Is Still Pushing for a Dangerous Healthcare Repeal?–?Do GOP Candidates for Governor Agree?
Chairman Murkowski Issues Statement at Hearing on Wildland Fire Outlook
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News